A central mission of the UCLA SPORE in Brain Cancer is to stimulate, recruit, develop, and retain new investigators in the field of brain tumor research, with particular focus on translation of scientific discoveries to novel clinical applications. The future of brain cancer research lies in the continued creation and development of translational projects and innovative investigators at major research institutions, as well as an institutional commitment to support outstanding, dedicated scientists in the field. In order for translational scientists and physician-investigators to grow and flourish, funding support and peer mentorship is imperative. The UCLA SPORE in Brain Cancer Career Enhancement Program (CEP) will provide this research support and mentoring resource, allowing junior faculty to transition to independent investigator status with adequate peer-reviewed funding and established investigators to focus or redirect their research to the area of brain cancer. CEP funds will be designated to prepare investigators for careers in translational brain cancer research and enhance their chances of success in the field. Applications will be accepted from MD, PhD, or MD/PhD advanced post- doctoral fellows who are ready to transition to a faculty position within one year, junior faculty, and established investigators to work with a senior mentor, and special efforts will be made to recruit qualified women, individuals from underrepresented racial and ethnic groups, as well as individuals with disabilities. Applications will be reviewed by the CEP Selection Committee, IAB and EAB members, and ad hoc reviewers with particular areas of expertise. Each year, we anticipate supporting 2 to 3 highly innovative candidates with CEP funds. Ultimately, the CEP is designed to increase scientific inquiry and excellence across the continuum of research on the prevention, early detection, diagnosis and precision therapy for brain cancer.

Public Health Relevance

CEP: Career Enhancement Program NARRATIVE A central mission of the UCLA SPORE in Brain Cancer is to stimulate, recruit, develop and retain new investigators in brain cancer research, with particular focus on translation of scientific discoveries to novel clinical applications. The SPORE Career Enhancement Program will enhance the career development of such new and continuing investigators in the field. Addressing the overall problem of brain cancer will require us to train the next generation of investigators who will focus their career attention on translational/clinical research in the most important aspects of this field.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA211015-02
Application #
9543457
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kong, Xiao-Tang; Nguyen, Nhung T; Choi, Yoon J et al. (2018) Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 100:1195-1203
Olar, Adriana; Goodman, Lindsey D; Wani, Khalida M et al. (2018) A gene expression signature predicts recurrence-free survival in meningioma. Oncotarget 9:16087-16098
Lillehei, Kevin O; Kalkanis, Steven N; Liau, Linda M et al. (2018) Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry. CNS Oncol 7:CNS08
Calais, Jeremie; Fendler, Wolfgang P; Eiber, Matthias et al. (2018) Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. J Nucl Med 59:434-441
Ohashi, Minori; Korsakova, Elena; Allen, Denise et al. (2018) Loss of MECP2 Leads to Activation of P53 and Neuronal Senescence. Stem Cell Reports 10:1453-1463
Goode, Benjamin; Mondal, Gourish; Hyun, Michael et al. (2018) A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nat Commun 9:810
Patel, Chirag B; Fazzari, Elisa; Chakhoyan, Ararat et al. (2018) 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol 139:399-409
Davidson, Tom B; Lee, Alexander H; Hsu, Melody et al. (2018) Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation. Clin Cancer Res :
Zheng, Feibi; Zhou, Hui; Li, Ning et al. (2018) Skeletal effects of failed parathyroidectomy. Surgery 163:17-21
Harris, Robert J; Yao, Jingwen; Chakhoyan, Ararat et al. (2018) Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med 80:1962-1978

Showing the most recent 10 out of 91 publications